AQR Arbitrage LLC - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K105. A total of 46 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Arbitrage LLC ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q2 2023$862,628
+1.0%
79,873
-0.2%
0.04%
+42.3%
Q1 2023$854,389
-77.1%
79,999
-78.0%
0.03%
-72.9%
Q4 2022$3,738,055
+2.0%
362,9180.0%0.10%
+18.5%
Q3 2022$3,665,000
+0.7%
362,9180.0%0.08%
-1.2%
Q2 2022$3,640,000
+0.3%
362,9180.0%0.08%
-13.7%
Q1 2022$3,629,000
+10.4%
362,918
+9.5%
0.10%
+13.1%
Q4 2021$3,286,000331,5350.08%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 108,103$1,177,7820.32%
METEORA CAPITAL, LLC 169,897$1,841,6830.31%
Mint Tower Capital Management B.V. 141,089$1,5320.24%
BERKLEY W R CORP 47,199$512,5810.03%
Shaolin Capital Management LLC 50,000$5430.02%
CLEAR STREET LLC 73,364$7970.01%
Walleye Capital LLC 47,936$520,5850.00%
Walleye Trading LLC 26,964$292,8290.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,588$114,9850.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders